AKESF
Price
$13.59
Change
+$0.39 (+2.95%)
Updated
Apr 25 closing price
Capitalization
11.44B
CPMV
Price
$0.65
Change
-$0.11 (-14.47%)
Updated
Apr 24 closing price
Capitalization
4.71M
Ad is loading...

AKESF vs CPMV

Header iconAKESF vs CPMV Comparison
Open Charts AKESF vs CPMVBanner chart's image
AKESO
Price$13.59
Change+$0.39 (+2.95%)
Volume$82.83K
Capitalization11.44B
Mosaic ImmunoEngineering
Price$0.65
Change-$0.11 (-14.47%)
Volume$1.05K
Capitalization4.71M
AKESF vs CPMV Comparison Chart
Loading...
View a ticker or compare two or three
VS
AKESF vs. CPMV commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKESF is a Hold and CPMV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (AKESF: $13.59 vs. CPMV: $0.65)
Brand notoriety: AKESF and CPMV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKESF: 604% vs. CPMV: 110%
Market capitalization -- AKESF: $11.44B vs. CPMV: $4.71M
AKESF [@Biotechnology] is valued at $11.44B. CPMV’s [@Biotechnology] market capitalization is $4.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKESF’s FA Score shows that 1 FA rating(s) are green whileCPMV’s FA Score has 0 green FA rating(s).

  • AKESF’s FA Score: 1 green, 4 red.
  • CPMV’s FA Score: 0 green, 5 red.
According to our system of comparison, AKESF is a better buy in the long-term than CPMV.

Price Growth

AKESF (@Biotechnology) experienced а +26.83% price change this week, while CPMV (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

CPMV is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
AKESF($11.4B) has a higher market cap than CPMV($4.71M). AKESF YTD gains are higher at: 94.143 vs. CPMV (-7.302).
AKESFCPMVAKESF / CPMV
Capitalization11.4B4.71M242,192%
EBITDAN/A-984.11K-
Gain YTD94.143-7.302-1,289%
P/E Ratio25.37N/A-
RevenueN/A0-
Total CashN/A5.74K-
Total DebtN/A1.45M-
FUNDAMENTALS RATINGS
CPMV: Fundamental Ratings
CPMV
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
52
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRLAX19.340.15
+0.78%
T. Rowe Price Latin America
SCJCX7.250.04
+0.55%
Steward Covered Call Income C
VEMPX318.320.59
+0.19%
Vanguard Extended Market Index InstlPlus
OAYWX23.600.03
+0.13%
Oakmark Global Select Advisor
IAUTX25.01-0.02
-0.08%
Invesco Dividend Income A

AKESF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKESF has been loosely correlated with INBX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AKESF jumps, then INBX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKESF
1D Price
Change %
AKESF100%
+2.95%
INBX - AKESF
45%
Loosely correlated
+2.34%
SMMT - AKESF
27%
Poorly correlated
-36.06%
NUVL - AKESF
25%
Poorly correlated
-0.68%
BNTX - AKESF
23%
Poorly correlated
-15.36%
CPMV - AKESF
22%
Poorly correlated
N/A
More

CPMV and

Correlation & Price change

A.I.dvisor tells us that CPMV and RANI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPMV and RANI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPMV
1D Price
Change %
CPMV100%
N/A
RANI - CPMV
23%
Poorly correlated
N/A
AKESF - CPMV
22%
Poorly correlated
+2.95%
PPTDF - CPMV
21%
Poorly correlated
N/A
SIGY - CPMV
6%
Poorly correlated
-14.94%
HLOSF - CPMV
5%
Poorly correlated
N/A
More